Bioprocessing - Upstream & Downstream

The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.

Is the complexity of the fill-finish process under appreciated in pharma manufacturing? Four experts discuss why it’s important to get it right.

Mistakes in fill-finish can lead to lost batches, lost profits, and increased regulatory scrutiny. Four experts discuss.

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.

From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

As biologics become more complex, mass spec becomes more indispensable than ever in the drug developer’s toolbox.

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Biopharma has been using lyophilization to stabilize injectables for more than 80 years, but the technique is capable of so much more.